Envision Healthcare Corporation (NYSE:EVHC) issued an update on its third quarter earnings guidance on Monday morning. The company provided earnings per share (EPS) guidance of $0.87-0.83 for the period, compared to the Thomson Reuters consensus estimate of $0.96. Envision Healthcare Corporation also updated its FY17 guidance to $3.35-3.45 EPS.

Shares of Envision Healthcare Corporation (EVHC) traded down 1.33% during mid-day trading on Monday, hitting $55.05. The stock had a trading volume of 2,272,795 shares. The firm’s market cap is $6.39 billion. Envision Healthcare Corporation has a one year low of $53.12 and a one year high of $74.75. The company has a 50-day moving average of $60.18 and a 200 day moving average of $61.73.

A number of research analysts have recently commented on EVHC shares. Cantor Fitzgerald reissued a buy rating and set a $80.00 price objective on shares of Envision Healthcare Corporation in a report on Tuesday, July 4th. Zacks Investment Research raised Envision Healthcare Corporation from a strong sell rating to a buy rating and set a $70.00 price objective on the stock in a report on Tuesday, July 4th. Royal Bank Of Canada reissued a buy rating and set a $72.00 price objective on shares of Envision Healthcare Corporation in a report on Monday, June 5th. Jefferies Group LLC reissued a buy rating and set a $71.00 price objective (down previously from $75.00) on shares of Envision Healthcare Corporation in a report on Wednesday, May 3rd. Finally, Mizuho lowered their price objective on Envision Healthcare Corporation from $70.00 to $60.00 and set a neutral rating on the stock in a report on Tuesday, May 30th. One analyst has rated the stock with a sell rating, two have given a hold rating, ten have assigned a buy rating and one has issued a strong buy rating to the stock. The stock has a consensus rating of Buy and an average price target of $71.89.

In other Envision Healthcare Corporation news, insider Robert Jon Coward sold 1,500 shares of the firm’s stock in a transaction that occurred on Monday, July 3rd. The stock was sold at an average price of $62.69, for a total value of $94,035.00. Following the sale, the insider now owns 97,863 shares of the company’s stock, valued at approximately $6,135,031.47. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 3.10% of the company’s stock.

ILLEGAL ACTIVITY WARNING: This piece of content was reported by American Banking News and is the property of of American Banking News. If you are accessing this piece of content on another site, it was illegally stolen and republished in violation of US and international copyright & trademark legislation. The legal version of this piece of content can be viewed at https://www.americanbankingnews.com/2017/08/07/envision-healthcare-corporation-evhc-releases-q3-earnings-guidance.html.

About Envision Healthcare Corporation

Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.

Receive News & Ratings for Envision Healthcare Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare Corporation and related companies with MarketBeat.com's FREE daily email newsletter.